ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's, Coya Therapeutics ink licensing agreement for ALS cure drug
Dr Reddy's Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop a combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Dr Reddy's Laboratories SA and Coya have entered into a
Announcement as on 06 December 2023

US regulators inspect Dr Reddy's, other Indian pharma majors: Report
Rivals Sun Pharma's Dadra facility and Torrent Pharmaceuticals Ltd's oncology unit are also undergoing FDA inspections
Announcement as on 05 December 2023

Dr Reddy's, Glenmark recall products in US due to manufacturing issues
Dr Reddy's Laboratories, Glenmark Pharma and Zydus are recalling products in the US market for manufacturing issues, according to the US Food and Drug Administration (USFDA). In its latest enforcement report, the US health regulator said Princeton-based Dr
Announcement as on 22 November 2023

Dr Reddy's rolls out wearable device for migraine management
Dr Reddy's Laboratories has introduced Nerivio, a wearable therapy device for drug-free migraine management, approved by the US FDA. Nerivio is a prescription-based non-invasive device for acute and prophylactic migraine treatment for people aged 12 and ab
Announcement as on 16 November 2023

Dr Reddy's launches wearable device for drug-free management of migraine
In January this year, Dr Reddy's entered an exclusive agreement with Theranica for the marketing and distribution of Nerivio in India
Announcement as on 16 November 2023

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.28
  • 12Day Average: 14.53
  • 20Day Average: 14.06
  • 50Day Average: 13.66
  • 100Day Average: 13.75
  • 150Day Average: 13.77
  • 200Day Average: 13.84

RDY Indicators & signals

Indicator MACD (12,26,9)

14.24, 14.04, 0.26
Indicator MACD is in positive zone

Indicator ADX (14)

10.34, 30.95, 38.1
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.37 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.16 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 0.81 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.35 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.65 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.05 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.01 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.58 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.1 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.37 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.92 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.23 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top